51³Ô¹ÏÍø

Dexcom CEO Jake Leach on Elliot Stake, Growth

Dexcom shares are up 3.4% in premarket trading after the diabetes device maker gave long-term growth outlook at its Investor Day, that impressed analysts. Separately, activist investor Elliott Investment Management took a stake in the company and struck a settlement that will put two independent directors on the board. Dexcom CEO Jake Leach speaks exclusively with Bloomberg TV's Dani Burger and Matthew Miller on May 15, 2026 in an unspecified location in the United States. (Footage by Bloomberg Television via Getty Images)
Dexcom shares are up 3.4% in premarket trading after the diabetes device maker gave long-term growth outlook at its Investor Day, that impressed analysts. Separately, activist investor Elliott Investment Management took a stake in the company and struck a settlement that will put two independent directors on the board. Dexcom CEO Jake Leach speaks exclusively with Bloomberg TV's Dani Burger and Matthew Miller on May 15, 2026 in an unspecified location in the United States. (Footage by Bloomberg Television via Getty Images)
RESTRICTED ASSET
This clip cannot be licensed online. To license this clip, please contact us.

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses.Clip pricing is on a per second basis. Please contact your Getty Images representative for further assistance.
Credit:
Bloomberg Television
Editorial #:
2276488919
Collection:
Bloomberg Television
Date created:
May 15, 2026
Upload date:
License type:
Rights-ready
Release info:
Not released.ÌýMore information
Clip length:
00:02:50:25
Location:
UNSPECIFIED, United States
Mastered to:
MPEG-4 10-bit H.264 HD 1920x1080 29.97p
Originally shot on:
XDCAM HD422
Source:
Bloomberg Television
Object name:
chunk_dexcom_0515